Clinical Trials Directory

Trials / Completed

CompletedNCT03265340

Clinical Effect of dTMS in Major Depressive Disorder

Clinical Effect of Deep Transcranial Magnetic Stimulation (dTMS) in Three Different Doses for the Treatment of Major Depressive Disorder

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
29 (actual)
Sponsor
Section for Affective Disorders; Northern Stockholm Psychiatry · Academic / Other
Sex
All
Age
18 Years – 100 Years
Healthy volunteers
Not accepted

Summary

Aim: To test if there is a relation between deep Transcranial Magnetic Stimulation (dTMS) dose and clinical effect on Major Depressive Disorder (MDD) Method: 30 patients with moderate to severe MDD without concurrent medication will be randomised to three different treatment protocols of dTMS. Symptom severity of MDD will be quantified before, during and after dTMS.

Detailed description

population: inclusion criteria: 1. Ongoing episode of MDD (ICD10 F32.x) according to MINI/SCID1. 2. Montgomery Asberg Depression Rating Scale (MADRS) score 20-60 3. TMS safe exclusion criteria: 1\. Bipolar disorder 2. Substance abuse 3. fluoxetine treatment last three weeks 4. Other major Central Nervous System (CNS) disorder 5. Acute medical disorders 6. previous TMS or Electro Convulsive Treatment (ECT) \<2 months before inclusion ratings: MADRS at inclusion, baseline, weekly, at last visit Clinical Global Impression Severity (CGI-S) score at baseline, at last visit Global Self-Evaluation-Memory (GSE-My) at last visit Alcohol Use Disorder Identification Test (AUDIT-C) at inclusion EuroQual 5 Dimension (EQ5D) at baseline, at last visit Quick Inventory of Depressive Symptomatology Self Rating (QIDS-SR) baseline, weekly, last visit condition: Each subject is randomised to condition A, B or C of dTMS (Brainsway): half the standard protocol (10 min; A), standard protocol (20 min; B) or double standard protocol (40 min, C). 20 treatment sessions/subject. 10 subjects in each group. Primary endpoint: MADRS at baseline - MADRS at last visit (Intention TO Treat (ITT), Last Observation Carried Forward (LOCF))

Conditions

Interventions

TypeNameDescription
DEVICEdTMS

Timeline

Start date
2014-09-01
Primary completion
2016-09-01
Completion
2016-09-01
First posted
2017-08-29
Last updated
2019-03-13

Locations

1 site across 1 country: Sweden

Source: ClinicalTrials.gov record NCT03265340. Inclusion in this directory is not an endorsement.